BMT CTN Protocol 0903

Allogeneic Hematopoietic Cell Transplant for Hematological Cancers and Myelodyplastic Syndromes in HIV-infected Patients

Below are protocol-related documents, which may be periodically updated.

            Protocol Chair: Joseph Alvarnas, MD

            Protocol Co-Chair: Richard Ambinder, MD (410-955-8839)

            Protocol Officer: Willis Navarro

            Protocol Coordinator: Kristin Knust (301-284-9182)

            Medical Monitor: Tammy Kindwall-Keller, MD



The BMT CTN 0903 study closed to new patient accrual on December 3, 2015.